A study published in the latest issue of the Alimentary Pharmacology & Therapeutics examines the adverse effects of interferon‐free regimens in chronic hepatitis C treated Egyptian patients.
May's issue of the European Journal of Gastroenterology & Hepatology examines age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.
The latest Alimentary Pharmacology & Therapeutics evaluates the impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection.
The latest issue of the Alimentary Pharmacology & Therapeutics developed a brief and reliable questionnaire assessing these constructs, the esophageal hypervigilance and anxiety scale.
A study in the most recent issue of the Diseases of the Esophagus provides an overview of the current status of instruments that assess eosinophilic esophagitis activity in the different domains.
The most recent issue of the European Journal of the Gastroenterology & Hepatology combines eastern and western practices for safe and effective endoscopic resection of large complex colorectal lesions.
This month's issue of Clinical Gastroenterology & Hepatology considers whether obesity, but not physical activity, is associated with higher prevalence of asymptomatic diverticulosis.
The most recent publication of Clinical Gastroenterology & Hepatology considers ethnic dispertion of primary sclerosing cholangitis in a multicenter North American consortium.
The latest publication of Gastroenterology reports that regular use of aspirin or non-aspirin nonsteroidal anti-inflammatory drugs is not associated with risk of incident pancreatic cancer.
This month's issue of Gut reports that the microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level.
April's issue of Gastroenterology considers the development and validation of a model to determine risk of progression of Barrett’s esophagus to neoplasia.
The latest publication of Gut reports on a genome-wide association study that identifies HLA-DR variants conferring risk of HBV-related acute-on-chronic liver failure.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .